2-氯-6-氟溴苯 | 309721-44-6

• 物质功能分类: 有机原料 - 烃类化合物及其衍生物 - 芳香烃
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氯-6-氟溴苯
• 中文别名: 2-溴-3-氟氯苯；2-溴-1-氯-3-氟苯；2-氟-6-氯溴苯
• 英文名称: 2-bromo-1-chloro-3-fluorobenzene
• 英文别名: 2-chloro-6-fluorobromobenzene；2-bromo-3-fluoro-chlorobenzene
• CAS: 309721-44-6
• 化学式: C₆H₃BrClF
• 分子量: 209.445
• InChiKey: GBESIUPWXGQOFP-UHFFFAOYSA-N

物化性质

• 沸点：
  198℃
• 密度：
  1.719
• 闪点：
  73℃

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2903999090
• 危险性防范说明：
  P305+P351+P338
• 危险性描述：
  H227,H315,H319,H335
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Bromo-1-chloro-3-fluorobenzene
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Bromo-1-chloro-3-fluorobenzene
CAS number: 309721-44-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H3BrClF
Molecular weight: 209.4

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen chloride, hydrogen fluoride, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氯-6-氟溴苯 在 bis(dibenzylideneacetone)-palladium⁽⁰⁾ sodium hydroxide 、 三氯化铝 、 (R)-(+)-2,2′-bis(diphenylphosphino)-1,1′-binaphthalene 、 sodium t-butanolate 作用下， 以 乙醇 、 水 、 甲苯 为溶剂， 反应 3.0h， 生成 罗美昔布
  参考文献：
  名称：

  新型N-芳基羟吲哚的合成作为药理活性化合物的中间体

  摘要：

  合成了各种新的N-芳基羟吲哚作为制备药理活性的2-（N-芳基氨基）-苯乙酸的中间体。除了布赫瓦尔德-芳基化和Smiles重排以外，还探索了两种新颖的方法来构建二芳基胺和N-芳基羟吲哚核心结构。苯胺与2-氧代-环己叉基-乙酸衍生物的缩合反应以及随后的脱氢反应是制备N-芳基羟吲哚的一种新的可行方法。

  DOI：

  10.1016/j.tet.2004.09.064
• 作为产物：
  描述：

  3-氯氟苯 在 正丁基锂 、 溴 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 15.0h， 以84%的产率得到2-氯-6-氟溴苯
  参考文献：
  名称：

  扩大耐水沮丧的路易斯对氢化的边界：路易斯酸中增强的反向应变使得羰基能够被还原胺化

  摘要：

  提出了以硼/氮为中心的失水路易斯对（FLP）的开发，该对具有极高的耐水性。随着对基于硼的路易斯酸（LA）组分的系统空间位阻揭示，增强的反向应变使水结合在存在相对强碱的情况下越来越可逆。这种进步使得FLP氢化的极限得以扩展，正如FLP羰基还原胺化所证明的那样。这种无金属的催化变体显示出广泛的化学选择性和通用性。

  DOI：

  10.1002/anie.201703591

文献信息

• ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE
  申请人：SAMSUNG SDI CO., LTD.

  公开号：US20200144508A1

  公开（公告）日：2020-05-07

  An organic optoelectronic device and a display device including the organic optoelectronic device, the organic optoelectronic device including an anode and a cathode facing each other, a light emitting layer between the anode and the cathode, a hole transport layer between the anode and the light emitting layer, and a hole transport auxiliary layer between the light emitting layer and the hole transport layer, wherein the light emitting layer includes a first compound represented by Chemical Formula 1 and a second compound represented by Chemical Formula 2, and the hole transport auxiliary layer includes a third compound represented by Chemical Formula 3,

  一种有机光电器件和包括该有机光电器件的显示器件，该有机光电器件包括彼此面对的阳极和阴极，位于阳极和阴极之间的发光层，位于阳极和发光层之间的空穴传输层，以及位于发光层和空穴传输层之间的空穴传输辅助层，其中发光层包括化学式1表示的第一化合物和化学式2表示的第二化合物，空穴传输辅助层包括化学式3表示的第三化合物。
• COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE
  申请人：SAMSUNG SDI CO., LTD.

  公开号：US20210184128A1

  公开（公告）日：2021-06-17

  The present invention is related to a first compound for an organic optoelectronic device represented by Chemical Formula 1, a composition for an organic optoelectronic device including the same, an organic optoelectronic device, and a display device. In Chemical Formula 1, definitions of each substituent are the same as defined in the specification.

  本发明涉及一种有机光电器件的第一化合物，其化学式表示为化学式1，包括该化合物的有机光电器件的组合物，有机光电器件以及显示装置。 在化学式1中，每个取代基的定义与规范中定义的相同。
• Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
  申请人：Novartis AG

  公开号：US06291523B1

  公开（公告）日：2001-09-18

  Disclosed are the compounds of formula I wherein R is methyl or ethyl; R1 is chloro or fluoro; R2 is hydrogen or fluoro; R3 is hydrogen, fluoro, chloro, methyl, ethyl, methoxy, ethoxy or hydroxy; R4 is hydrogen or fluoro; and R5 is chloro, fluoro, trifluoromethyl or methyl; and pharmaceutically acceptable salts thereof, as selective COX-2 cyclooxygenase inhibitors; and pharmaceutically acceptable prodrug esters thereof.

  公开的是以下式I的化合物 其中R是甲基或乙基；R1是氯或氟；R2是氢或氟；R3是氢、氟、氯、甲基、乙基、甲氧基、乙氧基或羟基；R4是氢或氟；R5是氯、氟、三氟甲基或甲基；以及其药学上可接受的盐，作为选择性COX-2环氧合酶抑制剂；以及其药学上可接受的前药酯。
• [EN] 2,4,6,7-TETRAHYDRO-PYRAZOLO[4,3-D]PYRIMIDIN-5-ONE DERIVATIVES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS FOR TREATING VASCULITIS AND INFLAMMATORY DISEASES<br/>[FR] DÉRIVÉS DE 2,4,6,7-TÉTRAHYDRO-PYRAZOLO[4,3-D]PYRIMIDIN-5-ONE ET COMPOSÉS APPARENTÉS EN TANT QUE MODULATEURS DU RÉCEPTEUR C5A POUR LE TRAITEMENT DE LA VASCULARITE ET DE MALADIES INFLAMMATOIRES
  申请人：IDORSIA PHARMACEUTICALS LTD

  公开号：WO2019137927A1

  公开（公告）日：2019-07-18

  The present invention relates to derivatives of formula (I) wherein Ring A, X, Y, Z, RA, R1, R2, R3 and R4 are The present invention discloses derivatives of formula (I), wherein Ring A, X, Y, Z, RA, R1, R2, R3 and R4 are as described in the description, and in particular e.g. 2,4,6,7-tetrahydro-pyrazolo[4,3- d]pyrimidin-5-one derivatives and related compounds, their preparation, pharmaceutically acceptable salts thereof, their use as pharmaceuticals, pharmaceutical compositions containing one or more compounds of formula (I), and especially their use as C5a receptor modulators for treating e.g. vasculitis and inflammatory diseases.

  本发明涉及式(I)的衍生物，其中环A、X、Y、Z、RA、R1、R2、R3和R4如描述中所述。本发明公开了式(I)的衍生物，其中环A、X、Y、Z、RA、R1、R2、R3和R4如描述中所述，特别是例如2,4,6,7-四氢吡唑并[4,3-d]嘧啶-5-酮衍生物及相关化合物，它们的制备，其药学上可接受的盐，它们作为药物的用途，含有式(I)一个或多个化合物的药物组合物，特别是它们作为C5a受体调节剂用于治疗例如血管炎和炎症性疾病。
• Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ) Agonist for Use in Treating Cancer
  作者：Thomas D. Aicher、Chad A. Van Huis、Alexander R. Hurd、Donald J. Skalitzky、Clarke B. Taylor、Omar M. Beleh、Gary Glick、Peter L. Toogood、Bing Yang、Tao Zheng、Changxin Huo、Jie Gao、Chenxi Qiao、Xiaolong Tian、Junping Zhang、Kellie Demock、Ling-Yang Hao、Charles A. Lesch、Rodney W. Morgan、Jacques Moisan、Yahong Wang、JoAnn Scatina、Chrystal M. Paulos、Weiping Zou、Laura L. Carter、Xiao Hu

  DOI：10.1021/acs.jmedchem.1c00731

  日期：2021.9.23

  hypothesized to render immune infiltrates more effective at countering tumor growth. To test this hypothesis, a family of benzoxazines was optimized to provide LYC-55716 (37c), a potent, selective, and orally bioavailable small-molecule RORγ agonist. LYC-55716 decreases tumor growth and enhances survival in preclinical tumor models and was nominated as a clinical development candidate for evaluation in

  视黄酸受体相关孤儿受体 γ（RORc、RORγ 或 NR1F3）是核受体主转录因子，可驱动产生 IL-17 的 T 辅助细胞 (Th17)、细胞毒性 T 细胞 (Tc17) 和细胞的功能和发育。先天淋巴细胞的亚群。假设肿瘤微环境中 RORγ + T 细胞的激活可以使免疫浸润更有效地对抗肿瘤生长。为了检验这一假设，对苯并嗪家族进行了优化，以提供 LYC-55716 ( 37c )，这是一种有效的、选择性的、口服生物可利用的小分子 RORγ 激动剂。 LYC-55716 可减少临床前肿瘤模型中的肿瘤生长并提高生存率，并被提名为用于实体瘤患者评估的临床开发候选药物。